TY - BOOK
T1 - Breast cancer and molecular medicine
AU - Piccart, Martine J.
AU - Wood, William C.
AU - Hung, Chie Mien
AU - Solin, Lawrence J.
AU - Cardoso, Fatima
PY - 2006
Y1 - 2006
N2 - As molecular-based medicine takes center stage due to the increasing knowledge of breast cancer molecular biology treatment tailoring is no longer a dream for the future but the main goal of current research. This book provides an overview of the most recent techniques, agents and approaches for breast cancer contributing to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular biology knowledge into the clinical management of patients, leading to increased survival as well as improved quality of life. Particular attention is given here to organ-specific tailored approaches, specific populations, patients' preferences and rehabilitation. Also discussed in depth are the respective roles of pharmacotherapeutics modelling, functional imaging, molecular staging, genomics and proteomics and their impact on the "re-classification" of breast cancer, as well as the clinical applications of basic science. The crucial issues of how to best integrate biological markers, new technologies, and new diagnostic and therapeutic approaches into clinical trials and practice are addressed.
AB - As molecular-based medicine takes center stage due to the increasing knowledge of breast cancer molecular biology treatment tailoring is no longer a dream for the future but the main goal of current research. This book provides an overview of the most recent techniques, agents and approaches for breast cancer contributing to the individualization of treatment. Current biomedical research focuses on facilitating the transfer of molecular biology knowledge into the clinical management of patients, leading to increased survival as well as improved quality of life. Particular attention is given here to organ-specific tailored approaches, specific populations, patients' preferences and rehabilitation. Also discussed in depth are the respective roles of pharmacotherapeutics modelling, functional imaging, molecular staging, genomics and proteomics and their impact on the "re-classification" of breast cancer, as well as the clinical applications of basic science. The crucial issues of how to best integrate biological markers, new technologies, and new diagnostic and therapeutic approaches into clinical trials and practice are addressed.
UR - http://www.scopus.com/inward/record.url?scp=84890002612&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890002612&partnerID=8YFLogxK
U2 - 10.1007/978-3-540-28266-2
DO - 10.1007/978-3-540-28266-2
M3 - Book
AN - SCOPUS:84890002612
SN - 3540282653
SN - 9783540282655
BT - Breast cancer and molecular medicine
PB - Springer Berlin Heidelberg
ER -